ACT Venture Partners

RS Research is a clinical-stage biotechnology company based in Istanbul, Turkey, focused on developing innovative nanomedicines for targeted cancer therapies. Founded in 2015, the company has established a proprietary drug delivery platform, Sagitta®, which enables the design of targeted drug candidates for various indications. RS Research's pipeline includes several proprietary programs in different stages of preclinical and clinical development, with its lead candidate, RS-0139, currently undergoing Phase I clinical trials in oncology patients. In addition to drug development, RS Research offers a range of services, including preclinical absorption, distribution, metabolism, and excretion studies, bioanalytical and analytical testing, and patent consulting. The company operates a GMP-certified production facility for clinical batch drug candidates and has successfully engaged in co-development projects with international partners, showcasing its commitment to advancing cancer treatment through modern therapeutic approaches.

Inofab Health specializes in innovative respiratory care solutions for both home and professional settings, focusing on patients with asthma, COPD, and cystic fibrosis. The company offers a comprehensive software platform that facilitates functional respiratory care management, incorporating advanced ultrasonic spirometers and connected inhaler attachments. These devices emphasize misuse detection and provide medical-grade accuracy in monitoring lung function. Inofab Health's technology enables patients to track their respiratory health effectively, while also allowing healthcare providers to diagnose and manage conditions efficiently. The platform is designed to alert users to any declines in lung health, facilitating timely interventions to prevent symptom onset and reduce unnecessary hospitalizations.

Segmentify is an e-commerce personalization platform that assists online retailers in optimizing conversion rates by creating tailored shopping experiences for individual visitors. The company offers client management software that delivers powerful insights and real-time analytics, enabling e-commerce managers to make informed decisions regarding campaigns and discounts. By focusing on customer-based campaigns, Segmentify helps clients enhance their sales performance and better meet customer needs, ultimately driving business growth in the competitive online retail landscape.

Skysens Teknoloji A.S. is an industrial Internet of Things (IoT) company based in Istanbul, Turkey, specializing in the development of scalable end-to-end IoT solutions. Founded in 2015, Skysens designs unique hardware and software that enables connectivity with various industrial machinery, regardless of their data output capabilities. Its offerings include smart industry solutions for factories, smart grids for energy monitoring, smart cities for efficient management of urban resources, and smart business applications to enhance logistics and warehouse operations. The company's devices utilize LoRaWAN-compliant technology to transmit data to gateways, which then relay information to the Skysens cloud platform. This platform provides users with real-time analytics and control over their devices, facilitating a transition to Industry 4.0. Skysens aims to optimize industrial facilities by offering predictive monitoring and actionable insights, thereby improving operational efficiency. Since receiving seed investment in 2017, Skysens has been expanding its reach internationally.

TeamSQL is a Multi-Platform SQL client built for collaboration, usability and performance. It supports popular database engines used by the majority and runs on macOS, Windows and Linux.

Segmentify is an e-commerce personalization platform that assists online retailers in optimizing conversion rates by creating tailored shopping experiences for individual visitors. The company offers client management software that delivers powerful insights and real-time analytics, enabling e-commerce managers to make informed decisions regarding campaigns and discounts. By focusing on customer-based campaigns, Segmentify helps clients enhance their sales performance and better meet customer needs, ultimately driving business growth in the competitive online retail landscape.

GlakoLens is a Turkey-based company specializing in the development of contact lens-based biosensor technologies aimed at managing ocular hypertension and glaucoma. The company provides non-invasive solutions for continuous monitoring of intraocular pressure (IOP), enabling accurate diagnosis and passive tracking of fluctuations in eye pressure. By measuring specific properties of the eye, GlakoLens' technology equips healthcare professionals with valuable insights to enhance the treatment of glaucoma, improving patient outcomes through advanced monitoring devices.

Inofab Health specializes in innovative respiratory care solutions for both home and professional settings, focusing on patients with asthma, COPD, and cystic fibrosis. The company offers a comprehensive software platform that facilitates functional respiratory care management, incorporating advanced ultrasonic spirometers and connected inhaler attachments. These devices emphasize misuse detection and provide medical-grade accuracy in monitoring lung function. Inofab Health's technology enables patients to track their respiratory health effectively, while also allowing healthcare providers to diagnose and manage conditions efficiently. The platform is designed to alert users to any declines in lung health, facilitating timely interventions to prevent symptom onset and reduce unnecessary hospitalizations.

RS Research is a clinical-stage biotechnology company based in Istanbul, Turkey, focused on developing innovative nanomedicines for targeted cancer therapies. Founded in 2015, the company has established a proprietary drug delivery platform, Sagitta®, which enables the design of targeted drug candidates for various indications. RS Research's pipeline includes several proprietary programs in different stages of preclinical and clinical development, with its lead candidate, RS-0139, currently undergoing Phase I clinical trials in oncology patients. In addition to drug development, RS Research offers a range of services, including preclinical absorption, distribution, metabolism, and excretion studies, bioanalytical and analytical testing, and patent consulting. The company operates a GMP-certified production facility for clinical batch drug candidates and has successfully engaged in co-development projects with international partners, showcasing its commitment to advancing cancer treatment through modern therapeutic approaches.

TeamSQL is a Multi-Platform SQL client built for collaboration, usability and performance. It supports popular database engines used by the majority and runs on macOS, Windows and Linux.

BioCapSOL specializes in the extraction of biological content from plants and vegetables through the use of benign chemistries. The company employs advanced encapsulation technology to control the release of active ingredients based on various factors such as time, temperature, and chemical conditions. This innovative approach allows for the functionalization of natural extracts, catering to diverse applications across multiple sectors, including nanotechnology, biotechnology, pharmaceuticals, cosmetics, food, and textiles. By focusing on the synthesis and characterization of these natural extracts, BioCapSOL provides valuable solutions for scientists and researchers seeking to harness the potential of plant-based nanoparticles.

Segmentify is an e-commerce personalization platform that assists online retailers in optimizing conversion rates by creating tailored shopping experiences for individual visitors. The company offers client management software that delivers powerful insights and real-time analytics, enabling e-commerce managers to make informed decisions regarding campaigns and discounts. By focusing on customer-based campaigns, Segmentify helps clients enhance their sales performance and better meet customer needs, ultimately driving business growth in the competitive online retail landscape.

High-Tech company with high vision, and high end solutions. Anything connectable is in our coverage. This is not MDMing, this is providing a platform that fills the gap between services and devices. We let you manage your smart devices, your Things with sensors. Better to show than explain.